
Mevion Medical Systems: Global provider of innovative cancer therapies and pediatric care services.
Mevion Medical Systems, founded in Littleton, United States, is dedicated to revolutionizing cancer treatment and pediatric care through advanced proton therapy solutions. Their core mission is to make cutting-edge cancer therapies more accessible and effective for patients worldwide. Mevion offers the MEVION S250 Series, a state-of-the-art proton therapy system designed to provide precise and powerful treatment options for various types of cancer. The company focuses on delivering innovative healthcare technologies to medical institutions globally.
Notable affiliations include partnerships with leading healthcare providers such as Atlantic Health System and Atrium Health Levine Cancer Institute. Mevion has achieved significant milestones, including the deployment of their advanced MEVION S250i Proton Therapy System at the Kansas City Proton Institute and Siteman Cancer Center. These achievements underscore their impact on enhancing cancer treatment capabilities and improving patient outcomes. Through their pioneering technology, Mevion Medical Systems continues to make substantial contributions to the field of oncology.
Companies similar to Mevion Medical Systems include Bragg Peak Systems, Proton Therapy USA, Proton Treatment and Research Center and Ionix Medical.
Mevion Medical Systems was founded in 2004.
Mevion Medical Systems' headquarters is located in Littleton, MA, US.
Mevion Medical Systems' most recent funding round was for $150M (USD) in June 2018.
As of Jun 14, 2018, Mevion Medical Systems has raised a total of $627.3M (USD).
Mevion Medical Systems has 233 employees as of Feb 5, 2024.
Proton Treatment and Research Center
protons.com